European Agency OKs Malaria Vaccine for Possible Licensing

European regulators have given a green light to a prospective new malaria vaccine, setting it on the path to possible licensing and assessment by the World Health Organization. The European Medicines Agency said Friday that the drug known as "Mosquirix," or "RTS,S" should be licensed for babies and very young children, despite mixed results in efficacy testing. The GlaxoSmithKline-made drug, developed in partnership with the PATH Malaria Vaccine Initiative and with...

© La Voix de l'Amérique - vendredi 24 juillet 2015